The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good. And it's here not hear. People who portray themselves as intelligent but can't spell even the simplest of words. You're not dispeptic are you org?
simmo...
Funnily enough my AME is a bit whacky and he usually end up chatting away about something left field! The thing about a pilot medial is you have quite a long time in there with the AME and as you are paying (£££) for the privilege they don't tend to be in a rush to kick you out like most doctors
Simmo222,
please restrain yourself, btw still awaiting the astra partnership you said was coming ( from your inside sources ) ......
Org. Your clogging the board up. Go and have a cup of tea.
Atb
And an Aston.
Seb is Scinv another of your accounts?
I agree Ghia but Richard does know I'm building a house so needs to get on with it. He promised me I'll have a roof over my head by Christmas and a swimming pool by the Spring!
Ghia and other long termers. Good to read your posts.
Unlike org, scinv has made some interesting contributions. It's unfortunate that today he questioned RM's integrity and described the company as a joke. This may just have been frustration.
Org, on the other hand, is clearly desperate to push the covid-denialist agenda. It's tempting to make a wee list of his contradictions and post it repeatedly. For one, he claims that he'd never heard of this site before January, but his account is from 2013.
Org is the same poster that was touting IAG as a great investment several months ago.
Everyone has opinions they are not always correct. Also people’s decisions are made with different time frames in mind.
I’m confident of the long term outlook here so I’m happy to accumulate, my daughter now has a chunk of these in her s&s ISA courtesy of today’s weakness.
Ironically I’m also going to purchase her some speculative IAG shares before the end of the year.
The biggest thing for me about today’s news is that the company are serious about getting the drug into the patients that need it. MAP is a tool to do the right thing this virus season, the value that licensing or takeover will bring can come next year for all I care as long as patients in need have the ability to access SNG001 this year.
He conveniently doesn't listen, read or understand. This is not just about covid it is about much much more. I can't believe big pharma are not all over this. (They hopefully are!!) Every time RM speaks the potential just seems to grow. We are talking any virus that attacks the respiratory system right across the world. How do you put a price on that? Anyway time will tell. It is good news that it is becoming more and more available to folk who need it. Results won't be long in coming in.
org30 i dont understand why you would talk down your own holdings assuming you hold any which I doubt. Please explain the rationale to me? i'm all for debate and questioning things to find out the answers but to come out with phrases like the virus will be sorted makes me feel you are a school kid just trying to wind people up? why do you do it?
"They're not going to be able to distribute the kind of numbers quoted without some sort of emergency approval(s)"
Fair point. Hopefully they're in a position to get that in place before the end of the year.
you never know:
Boris Johnson to hold coronavirus press conference tomorrow
He will be joined by England's chief medical officer Professor Chris Whitty and chief scientific adviser Sir Patrick Vallance.
Hello HelloSanDiego, I'm not sure what you mean by 'But today's news means that it will reach the patients who need it this winter anyway'.
They're not going to be able to distribute the kind of numbers quoted without some sort of emergency approval(s) therefore I still expect too see that sooner rather than later (i.e this year). Also, they won't turn on 100's of thousands of doses like a light switch. It'll ramp up to that so it's not unreasonable to expect them to be supplying treatments this year (if they get the aforementioned approvals).
"I would not agree that we can forget about this year. The drug is badly needed for this winter and think we'll see it approved in some capacity this year."
But today's news means that it will reach the patients who need it this winter anyway. Plus, there will be considerably more data to back up the approval application soon.
I can't see why they would approve it before the current trial is complete, especially when the supply side isn't even in place.
Scinv. This is already stock of the year imop. Some of us bought at 18p or less.
Yeah for the next five minutes? We won’t hold our collective breath.
Do yourself a favour, put your energies into making money elsewhere as there’s clearly none to be made here lol
Scinv - you are sounding more and more desperate, being backed into a corner. It’s getting comical. Yes we get it you are trying to debunk the CEO’s words. I think you’d agree though that he can’t control factors outside of his control. We know it’s coming and, unlike you, we have patience.
But you keep on peddling furiously on your hamster wheel.
Youre actually questioning RMs integrity when his and the companies actions this year have given us no good reason to.
No Scinv, I would not agree that we can forget about this year. The drug is badly needed for this winter and think we'll see it approved in some capacity this year.
Scinv on the retreat lol
Perhaps 'short-circuit' is the wrong phrase - yes 'authorised' at speed for use with patients (and chargeable). Not a further trial not a full formal authorisation/license.
Its compassionate use when you are hospitalised, can't breathe and the next stage is ventilation, permanent damage and potential death. It clearly won't be the last resort because that's currently Dex.
If we agree (from your own words) 'it will ONLY be available to patients that are about to die' that is still market access and currently there is a lot of them and its growing.....
gkb47 - that’s right, even with a Managed Access Program, or should I say particularly with a MAP regulatory approval must still be given for that specific drug in that specific locality/jurisdiction (as they inevitably differ).
Scinv, the company are working towards producing 100's of thousands of treatments in 2021. They are currently in discussion with regulatory agencies about approvals. Why would they be in discussions with them now if the trial had to run its course until May next year?
You're clutching mate!
Scinv - Thanks for your response. Its good to have different / varied views and thoughts. Questions are good.
My post, is really a question to everyone not a statement of truth/knowledge.
I think your first point does illustrate how this Market Access approach helps to 'short circuit' potential requirements for official authorisations in the short term and generates more data for these in the longer term. BTW - I'm not trying to persuade you on this, its just a thought.
I don't really have any solids re: manufacturing. They (SNG) would have had to manufacture for the trials so my initial assumption (which could be wrong) would be that they would discuss with the original manufacturers on scaling, this is is (obviously) outsourced and would be sub-contracted directly/indirectly. Providing there's funding this will be completed.
(It looks like 100K per month in 2021 which is more specific than the previously vague millions of doses.)